Be a Smart Investor

Thursday, April 2, 2020

FDA OKs Addl. Treatment For Adults, Adolescents With Hemophilia A Or B

The U.S. Food and Drug Administration granted approval for Coagulation Factor VIIa (Recombinant) to biopharmaceutical company LFB S.A. for the treatment and control of bleeding episodes occurring in adults and adolescents - 12 years of age and older- with hemophilia A or B with inhibitors. It is marketed as Sevenfact by LFB.

from RTT - Biotech https://ift.tt/2USHQmg
via IFTTT

Stock Alert: Shopify Falls 8% After Suspending FY20 Outlook

Shares of Shopify Inc. (SHOP) are losing more than 8 percent in Thursday's trading at $353.58. The shares have traded in a range of $190.38 to $593.89 in the past 52 weeks.

from RTT - Earnings https://ift.tt/2UZi6Vi
via IFTTT

Another Spike In Jobless Claims Leads To Pullback By Futures

The major U.S. index futures are currently pointing to a higher opening on Thursday but have pulled back well off their earlier highs following the release of a Labor Department report showing another spike in initial jobless claims in the week ended March 28th.

from RTT - Market Analysis https://ift.tt/3aD2spd
via IFTTT

Stock Alert: Biomerica Shares Surge 25% In Pre-Market

Shares of Biomerica Inc. (BMRA) are soaring over 25% in pre-market today, after the company announced signing of two separate definitive license agreements with Mount Sinai's Icahn School of Medicine in New York to license technologies pertaining to a laboratory version serological test for SARS-CoV-2 virus infection which have been developed at Mount Sinai.

from RTT - Before the Bell https://ift.tt/2R4sPwt
via IFTTT

Acuity Brands Q2 Profit Declines, Miss Estimates - Quick Facts

Industrial technology company Acuity Brands, Inc. (AYI) reported Thursday that net income for the first quarter declined to $57.2 million or $1.44 per share from $66.3 million or $1.67 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/2xEAuLg
via IFTTT

WeWork founder threatens to sue after Softbank scraps rescue deal

Adam Neumann had been lined up to sell $970m of his own shares to Japanese investor

WeWork’s founder and former chief executive, Adam Neumann, has threatened to sue SoftBank, the office space company’s biggest investor, after it pulled out of deal to buy $3bn (£2.4bn) of WeWork shares – including almost $1bn from Neumann himself.

SoftBank, which is run by the Japanese billionaire Masayoshi Son, announced on Thursday that it was terminating a $3bn share tender rescue deal hammered out last October to save WeWork from collapse.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2R6IjAd

Stock Alert: ION Geophysical Sees Strong Revenues In Q1; Stock Up 173%

Shares of ION Geophysical Corp. (IO) are soaring over 170% in pre-market today, after the company announced that it expects first quarter 2020 revenues to be in the range of $56 million - $57 million, over 50% greater than the first quarter 2019 and over 30% greater than the fourth quarter 2019. Three Wall Street analysts have a consensus revenue estimate of $39.2 million for the quarter.

from RTT - Before the Bell https://ift.tt/3aBMV9n
via IFTTT